@EndoMedia

Media relations team for @TheEndoSociety. Links/RTs are not endorsements.

 Washington, DC
endocrine.org/news-room
Joined November 2011
  • Tweets6.7K
  • Following1.9K
  • Followers6.2K
Lead author of @TheEndoSociety's new obesity Scientific Statement, @DanielJDrucker, discusses the need for individualized treatment with @PatCareOnline
Patient Care@PatCareOnline
Sep 23
Obesity treatment is more than prescribing a medication. In a new video, Daniel Drucker, MD, shares how patient goals, comorbidities, lifestyle factors, and cardiometabolic health inform individualized care plans in #primarycare. 📽️➡️hubs.li/Q04y9W9Q0 @DanielJDrucker
218
Excited to listen to an all @TheEndoSociety episode of @scifri on perimenopause featuring women's health experts President Dr. Nanette Santoro and Dr. Genevieve Neal-Perry! bit.ly/4xvyv4g #menopause

Hot flashes, hormone therapy, and the science of perimenopause

After decades of controversy over prescribing hormone therapy for perimenopause, many providers are reconsidering their approach.

sciencefriday.com
2
207
.@TheEndoSociety Honors Endocrinology Field’s Leaders with 2027 Laureate Awards endocrinenews.endocrine.org/…

Endocrine Society Honors Endocrinology Field’s Leaders with 2027 Laureate Awards - Endocrine News

The Endocrine Society today announced it has chosen 13 leading endocrinologists as winners of its prestigious 2027 Laureate Awards, the top honors in the field. These professionals have achieved...

endocrinenews.endocrine.org
1
297
📋 A new @TheEndoSociety scientific statement calls for an approach to #obesity that extends beyond weight loss and highlights key areas for future research. Read more ⬇️ @EndoMedia @DanielJDrucker @GoHealio vist.ly/5hxqd
3
3
456
“We’re now in a position to transform our understanding of obesity,” @DanielJDrucker tells @globeandmail's @jyangreporter in an interview about @TheEndoSociety's new Scientific Statement. More details at bit.ly/4xLuvgH @EndoSocJournals
The Globe and Mail
@globeandmail
Sep 9
Endocrine Society publishes research roadmap for advancing obesity science in the era of GLP-1s theglobeandmail.com/canada/a…

Endocrine Society publishes research roadmap for advancing obesity science in the era of GLP-1s

Led by Canadian scientist Daniel Drucker the research will chart a path toward improved health, optimized treatments and better understanding of obesity

theglobeandmail.com
2
3
582
Check out our press release for an overview of this important Scientific Statement exploring the obesity research and treatment landscape: bit.ly/4xLuvgH @TheEndoSociety @EndoSocJournals

Endocrine Society Scientific Statement provides research roadmap for what's next in obesity science

A new Scientific Statement released today by the Endocrine Society highlights the benefits of obesity treatment beyond weight loss, including improvements in overall health and reducing the risk of...

endocrine.org
Daniel J Drucker@DanielJDrucker
Sep 9
Replying to @TheEndoSociety
@TheEndoSociety has posted a new document published in Endocrine Reviews and free to read: Obesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine Society scientific statement @EndoSocJournals academic.oup.com/edrv/advanc…
2
251
📣 Today the Endocrine Society published a Scientific Statement highlighting the opportunities and research gaps within obesity medicine. 🔑 Essential points: 🧬 The pathophysiology of obesity with a focus on body fat regulation/defended fat mass 🔍 The heterogeneity of obesity with a focus on treatment response 🎯 Redefining treatment targets beyond percent total body weight loss 📈 The physiology of phases of treatment response to pharmacotherapy ❤️ Health outcomes with pharmacotherapy 🛡️ Safety of pharmacotherapy doi.org/10.1210/endrev/bnag0…

Obesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine...

Abstract. The medical management of obesity has been transformed by the introduction of obesity medicines (OMs), based on the actions of glucagon-like pept

academic.oup.com
2
31
1
126
38,243
Breaking news: @TheEndoSociety unveils Scientific Statement examining next steps as new medications continue to transform #obesity treatment. bit.ly/4xLuvgH @DanielJDrucker

Endocrine Society Scientific Statement provides research roadmap for what's next in obesity science

A new Scientific Statement released today by the Endocrine Society highlights the benefits of obesity treatment beyond weight loss, including improvements in overall health and reducing the risk of...

endocrine.org
222
Phthalate exposure may contribute to high blood pressure in pregnant women, according to a new study in the Journal of @TheEndoSociety. bit.ly/4g8h5Eb #EDCs @EndoSocJournals

Endocrine disrupting chemical exposure may be linked to high blood pressure during pregnancy

Phthalates, which are chemicals found in plastics, personal care products and hundreds of other consumer goods, may contribute to high blood pressure in pregnant women, according to a study published...

endocrine.org
2
2
476
New @CDCgov stats found 8.7% of women ages 22-49 had been diagnosed with polyendocrine metabolic ovarian syndrome (#PMOS), a common cause of infertility long known as #PCOS. bit.ly/3Ttz9AQ
229
🗣️ Dr. Stephanie Roberts, cochair of a new clinical practice guideline for central precocious puberty, discusses some of the key recommendations from the document. Read more 👇 @TheEndoSociety @EndoMedia @BostonChildrens @IDinChildren vist.ly/5byfp
2
2
419
Have questions about testosterone screening? Check out our statement on testosterone replacement therapy: bit.ly/4ffalnq @TheEndoSociety

Statement on Testosterone Replacement Therapy

The Society’s Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices.

endocrine.org
1
6
836
More than half of those who stop taking GLP-1 medications restart within a year, according to research presented at #ENDO2026. bit.ly/4vKOH1i @TheEndoSociety #obesity

More than half of those who stop GLP-1s restart within a year

People prescribed GLP-1 medications are more likely to start-and-stop than most people assume, according to a study being presented Sunday at ENDO 2026, the Endocrine Society’s annual meeting in...

endocrine.org
Gallup
@Gallup
Jul 7
The percentage of U.S. adults who currently take GLP-1 medications for weight loss purposes has risen to 11% in 2026, up significantly from 3% in 2024. And 15% report having used the medicine for weight loss at some point, an increase of nine percentage points.
1
4
1,584
Some of the leading research universities in the U.S. are admitting fewer students to their doctoral programs amid widespread concerns about federal funding cuts and uncertainty. wapo.st/4vOPKxc

Admissions to top PhD programs down 15% amid federal funding cuts, uncertainty

U.S. universities have warned Trump policies will narrow the talent pipeline. Already global applications are down, though domestic applications are up slightly.

washingtonpost.com
18
30
2
34
34,617
#ENDO2026 is a wrap! Proud of our team for issuing 20+ press releases, filming 12 videos, and answering countless media inquiries. See you in Toronto for #ENDO2027! – at Chicago, IL
2
2
7
870
James Baumgartner, CEO of @KeystoneSymp, and @TheEndoSociety leaders discuss the value of life sciences partnerships for researchers. More details at bit.ly/4eLE4VV #ENDO2026
3
2
6
2,104
#ENDO2026 in the headlines: GLP-1 medications could boost male testosterone levels and sperm count. bit.ly/3QGdNiF Via @people @TheEndoSociety @nhsuhcw

Study Shows GLP-1 Medications Could Boost Male Testosterone Levels and Sperm Count

GLP-1 medications could help male patients improve their testosterone levels and their fertility, a new study has found. The research determined that men ages 18-65 who participated in the study...

people.com
2
3
588
#ENDO2026 in the headlines: GLP-1s may improve fertility in men. bit.ly/4fMtPll Via @CNN @nhsuhcw @TheEndoSociety

Another possible benefit of GLP-1s? Improved male fertility | CNN

Not only are GLP-1 medications likely not harmful to male fertility, but they may help improve testosterone levels and sperm production, according to a new study.

cnn.com
3
6
458
Filming an interview with @TheEndoSociety Past-President Carol Lange and SBEM President Elect Karen De Marca. #ENDO2026
4
7
526
#ENDO2026 in the headlines: Study finds many patients stop and restart GLP-1 medications. bit.ly/4owB9nm Via @usnews @USNewsHealth @BUSPH @TheEndoSociety

Many Patients Stop And Restart GLP-1 Meds, Study Finds

usnews.com
2
5
513
Load more